Merck (MRK) Tops Q4 EPS by 1c, Offers FY Guidance
Get Alerts MRK Hot Sheet
Price: $130.72 +2.93%
EPS Growth %: +47.9%
Financial Fact:
Less: Net Income Attributable to Noncontrolling Interests: 122.8M
Today's EPS Names:
FRSB, DGICA, UXIN, More
EPS Growth %: +47.9%
Financial Fact:
Less: Net Income Attributable to Noncontrolling Interests: 122.8M
Today's EPS Names:
FRSB, DGICA, UXIN, More
Join SI Premium – FREE
Merck (NYSE: MRK) reported Q4 EPS of $1.04, $0.01 better than the analyst estimate of $1.03. Revenue for the quarter came in at $11 billion versus the consensus estimate of $10.94 billion.
GUIDANCE:
Merck sees FY2019 EPS of $4.57-$4.72, versus the consensus of $4.69. Merck sees FY2019 revenue of $43.2-44.7 billion, versus the consensus of $44.54 billion.
For earnings history and earnings-related data on Merck (MRK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Gilead Sciences (GILD) Misses Q1 EPS by 288c
- COPT Defense Properties (CDP) Reports In-Line Q1 EPS; offers guidance
- Merck (MRK) PT Raised to $143 at Truist Securities
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!